Mission
THE MISSION OF ANGIOMA ALLIANCE IS TO DRIVE A CURE FOR CAVERNOUS MALFORMATION AND IMPROVES LIVES FOR ALL AFFECTED.
Public Charity
ANGIOMA ALLIANCE DBA ALLIANCE TO CURE CAVERNOUS MALFORMATIONS
Based in CHARLOTTESVILLE, VA, ANGIOMA ALLIANCE DBA ALLIANCE TO CURE CAVERNOUS MALFORMATIONS operates as a Public Charity. The organization reported $1.4M in revenue, $1.3M in expenses, $1.1M in total assets for fiscal year 2025. Imperigo tracks 46 reported grant relationships connected to this organization totaling approximately $2.1M.
EIN: 020600697
CHARLOTTESVILLE, VA
Specifically Named Diseases
NTEE: G80
Latest filing: 2025
Total Revenue$1.4M
Total Expenses$1.3M
Total Assets$1.1M
Grant Records46
Funding Total$2.1M
Filing Years2021–2025
Where $100 goes at Angioma Alliance DBA Alliance to Cure Cavernous Malformations
How Angioma Alliance DBA Alliance to Cure Cavernous Malformations divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$81
Programs
the work itself
$6
Management
running the organization
$13
Fundraising
raising the next dollar
Inside the $81 for programs
$42
Facilitate and participate in cavernous malformation research to achieve a complete understanding of the disease and facilitate clinical drug trials and other treatment improvements
$33
Establish a network of clinical research centers in preparation for clinical drug trials and to facilitate consistent treatment
$6
Provide disease and resource information to educate and improve the lives of people affected by cavernous malformations, caregivers, health professionals, researchers, policymakers, the media, and the general public.To…
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
GENERAL SUPPORT
$5,265
For grant recipient's exempt purposes
$126,950
UNRESTRICTED
$125,845
$71,500
GENERAL SUPPORT
$48,593
Showing up to 5 of 46 total records — full history available with membership.
Officers & Directors
CEO
Cornelia Lee Psyd
CHAIR
David Borland
VICE CHAIR
Dorothy Robinson
INDUSTRY RELATIONS DIRECTORR
Jianbo Hu
DIRECTOR
John Andres
DIRECTOR
Joseph Zabramski Md
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $1.4M | $1.3M | $1.1M |
| 2024 | $1.3M | $1.4M | $1.1M |
| 2023 | $1.3M | $1.4M | $1.1M |
| 2022 | $1.1M | $800K | $1.2M |
| 2021 | $831K | $434K | $912K |
Between 2021 and 2025, reported annual revenue grew from $831K to $1.4M (+64%), with total assets most recently reported at $1.1M.
Interactive year-over-year charts and full filing details available with membership.